International Prognostic Scoring System (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "International Prognostic Scoring System" in English language version.

refsWebsite
Global rank English rank
4th place
4th place
2nd place
2nd place

doi.org

  • Greenberg PL, Tuechler H, Schanz J, Sanz G, Garcia-Manero G, Solé F, Bennett JM, Bowen D, Fenaux P, Dreyfus F, Kantarjian H, Kuendgen A, Levis A, Malcovati L, Cazzola M, Cermak J, Fonatsch C, Le Beau MM, Slovak ML, Krieger O, Luebbert M, Maciejewski J, Magalhaes SM, Miyazaki Y, Pfeilstöcker M, Sekeres M, Sperr WR, Stauder R, Tauro S, Valent P, Vallespi T, van de Loosdrecht AA, Germing U, Haase D (September 2012). "Revised international prognostic scoring system for myelodysplastic syndromes". Blood. 120 (12): 2454–65. doi:10.1182/blood-2012-03-420489. PMC 4425443. PMID 22740453.
  • Bernard E, Tuechler H, Greenberg PL, Hasserjian RP, Arango Ossa JE, Nannya Y, Devlin SM, Creignou M, Pinel P, Monnier L, Gundem G, Medina-Martinez JS, Domenico D, Jädersten M, Germing U, Sanz G, van de Loosdrecht AA, Kosmider O, Follo MY, Thol F, Zamora L, Pinheiro RF, Pellagatti A, Elias HK, Haase D, Ganster C, Ades L, Tobiasson M, Palomo L, Della Porta MG, Takaori-Kondo A, Ishikawa T, Chiba S, Kasahara S, Miyazaki Y, Viale A, Huberman K, Fenaux P, Belickova M, Savona MR, Klimek VM, Santos FP, Boultwood J, Kotsianidis I, Santini V, Solé F, Platzbecker U, Heuser M, Valent P, Ohyashiki K, Finelli C, Voso MT, Shih LY, Fontenay M, Jansen JH, Cervera J, Gattermann N, Ebert BL, Bejar R, Malcovati L, Cazzola M, Ogawa S, Hellström-Lindberg E, Papaemmanuil E (July 2022). "Molecular International Prognostic Scoring System for Myelodysplastic Syndromes". NEJM Evid. 1 (7): EVIDoa2200008. doi:10.1056/EVIDoa2200008. PMID 38319256.
  • Lee WH, Tsai MT, Tsai CH, Tien FM, Lo MY, Tseng MH, Kuo YY, Liu MC, Yang YT, Chen JC, Tang JL, Sun HI, Chuang YK, Lin LI, Chou WC, Lin CC, Hou HA, Tien HF (August 2023). "Validation of the molecular international prognostic scoring system in patients with myelodysplastic syndromes defined by international consensus classification". Blood Cancer J. 13 (1): 120. doi:10.1038/s41408-023-00894-8. PMC 10412560. PMID 37558665.

nih.gov

pubmed.ncbi.nlm.nih.gov

  • Greenberg PL, Tuechler H, Schanz J, Sanz G, Garcia-Manero G, Solé F, Bennett JM, Bowen D, Fenaux P, Dreyfus F, Kantarjian H, Kuendgen A, Levis A, Malcovati L, Cazzola M, Cermak J, Fonatsch C, Le Beau MM, Slovak ML, Krieger O, Luebbert M, Maciejewski J, Magalhaes SM, Miyazaki Y, Pfeilstöcker M, Sekeres M, Sperr WR, Stauder R, Tauro S, Valent P, Vallespi T, van de Loosdrecht AA, Germing U, Haase D (September 2012). "Revised international prognostic scoring system for myelodysplastic syndromes". Blood. 120 (12): 2454–65. doi:10.1182/blood-2012-03-420489. PMC 4425443. PMID 22740453.
  • Bernard E, Tuechler H, Greenberg PL, Hasserjian RP, Arango Ossa JE, Nannya Y, Devlin SM, Creignou M, Pinel P, Monnier L, Gundem G, Medina-Martinez JS, Domenico D, Jädersten M, Germing U, Sanz G, van de Loosdrecht AA, Kosmider O, Follo MY, Thol F, Zamora L, Pinheiro RF, Pellagatti A, Elias HK, Haase D, Ganster C, Ades L, Tobiasson M, Palomo L, Della Porta MG, Takaori-Kondo A, Ishikawa T, Chiba S, Kasahara S, Miyazaki Y, Viale A, Huberman K, Fenaux P, Belickova M, Savona MR, Klimek VM, Santos FP, Boultwood J, Kotsianidis I, Santini V, Solé F, Platzbecker U, Heuser M, Valent P, Ohyashiki K, Finelli C, Voso MT, Shih LY, Fontenay M, Jansen JH, Cervera J, Gattermann N, Ebert BL, Bejar R, Malcovati L, Cazzola M, Ogawa S, Hellström-Lindberg E, Papaemmanuil E (July 2022). "Molecular International Prognostic Scoring System for Myelodysplastic Syndromes". NEJM Evid. 1 (7): EVIDoa2200008. doi:10.1056/EVIDoa2200008. PMID 38319256.
  • Lee WH, Tsai MT, Tsai CH, Tien FM, Lo MY, Tseng MH, Kuo YY, Liu MC, Yang YT, Chen JC, Tang JL, Sun HI, Chuang YK, Lin LI, Chou WC, Lin CC, Hou HA, Tien HF (August 2023). "Validation of the molecular international prognostic scoring system in patients with myelodysplastic syndromes defined by international consensus classification". Blood Cancer J. 13 (1): 120. doi:10.1038/s41408-023-00894-8. PMC 10412560. PMID 37558665.

ncbi.nlm.nih.gov

  • Greenberg PL, Tuechler H, Schanz J, Sanz G, Garcia-Manero G, Solé F, Bennett JM, Bowen D, Fenaux P, Dreyfus F, Kantarjian H, Kuendgen A, Levis A, Malcovati L, Cazzola M, Cermak J, Fonatsch C, Le Beau MM, Slovak ML, Krieger O, Luebbert M, Maciejewski J, Magalhaes SM, Miyazaki Y, Pfeilstöcker M, Sekeres M, Sperr WR, Stauder R, Tauro S, Valent P, Vallespi T, van de Loosdrecht AA, Germing U, Haase D (September 2012). "Revised international prognostic scoring system for myelodysplastic syndromes". Blood. 120 (12): 2454–65. doi:10.1182/blood-2012-03-420489. PMC 4425443. PMID 22740453.
  • Lee WH, Tsai MT, Tsai CH, Tien FM, Lo MY, Tseng MH, Kuo YY, Liu MC, Yang YT, Chen JC, Tang JL, Sun HI, Chuang YK, Lin LI, Chou WC, Lin CC, Hou HA, Tien HF (August 2023). "Validation of the molecular international prognostic scoring system in patients with myelodysplastic syndromes defined by international consensus classification". Blood Cancer J. 13 (1): 120. doi:10.1038/s41408-023-00894-8. PMC 10412560. PMID 37558665.